T1rho-weighted MRI using a surface coil to transmit spin-lock pulses

Endogenous assessment of chronic myocardial infarction with T(1ρ)-mapping in patients

BACKGROUND

Detection of cardiac fibrosis based on endogenous magnetic resonance (MR) characteristics of the myocardium would yield a measurement that can provide quantitative information, is independent of contrast agent concentration, renal function and timing. In ex vivo myocardial infarction (MI) tissue, it has been shown that a significantly higher T(1ρ) is found in the MI region, and studies in animal models of chronic MI showed the first in vivo evidence for the ability to detect myocardial fibrosis with native T(1ρ)-mapping. In this study we aimed to translate and validate T(1ρ)-mapping for endogenous detection of chronic MI in patients.

METHODS

We first performed a study in a porcine animal model of chronic MI to validate the implementation of T(1ρ)-mapping on a clinical cardiovascular MR scanner and studied the correlation with histology. Subsequently a clinical protocol was developed, to assess the feasibility of scar tissue detection with native T(1ρ)-mapping in patients (n = 21) with chronic MI, and correlated with gold standard late gadolinium enhancement (LGE) CMR. Four T1ρ-weighted images were acquired using a spin-lock preparation pulse with varying duration (0, 13, 27, 45 ms) and an amplitude of 750 Hz, and a T(1ρ)-map was calculated. The resulting T(1ρ)-maps and LGE images were scored qualitatively for the presence and extent of myocardial scarring using the 17-segment AHA model.

RESULTS

In the animal model (n = 9) a significantly higher T(1ρ) relaxation time was found in the infarct region (61 ± 11 ms), compared to healthy remote myocardium (36 ± 4 ms) . In patients a higher T(1ρ) relaxation time (79 ± 11 ms) was found in the infarct region than in remote myocardium (54 ± 6 ms). Overlap in the scoring of scar tissue on LGE images and T(1ρ)-maps was 74%.

CONCLUSION

We have shown the feasibility of native T(1ρ)-mapping for detection of infarct area in patients with a chronic myocardial infarction. In the near future, improvements on the T(1ρ)-mapping sequence could provide a higher sensitivity and specificity. This endogenous method could be an alternative for LGE imaging, and provide additional quantitative information on myocardial tissue characteristics.

Characterization of non-hemodynamic functional signal measured by spin-lock fMRI

Current functional MRI techniques measure hemodynamic changes induced by neural activity. Alternative measurement of signals originated from tissue is desirable and may be achieved using T1ρ, the spin-lattice relaxation time in the rotating-frame, which is measured by spin-lock MRI. Functional T1ρ changes in the brain can have contributions from vascular dilation, tissue acidosis, and potentially other contributions. When the blood contributions were suppressed with a contrast agent at 9.4 T, a small tissue-originated T1ρ change was consistently observed at the middle cortical layers of cat visual cortex during visual stimulation, which had different dynamic characteristics compared to hemodynamic fMRI such as a faster response and no post-stimulus undershoot. Functional tissue T1ρ is highly dependent on the magnetic field strength and experimental parameters such as the power of the spin-locking pulse. With a 500Hz spin-locking pulse, the tissue T1ρ without the blood contribution increased during visual stimulation, but decreased during acidosis-inducing hypercapnia and global ischemia, indicating different signal origins. Phantom studies suggest that it may have contribution from concentration decrease in metabolites. Even though the sensitivity is much weaker than BOLD and its exact interpretation needs further investigation, our results show that non-hemodynamic functional signal can be consistently observed by spin-lock fMRI.

Quantification of T(1ρ) relaxation by using rotary echo spin-lock pulses in the presence of B(0) inhomogeneity

T(1ρ) relaxation is traditionally described as a mono-exponential signal decay with spin-lock time. However, T(1ρ) quantification by fitting to the mono-exponential model can be substantially compromised in the presence of field inhomogeneities, especially for low spin-lock frequencies. The normal approach to address this issue involves the development of dedicated composite spin-lock pulses for artifact reduction while still using the mono-exponential model for T(1ρ) fitting. In this work, we propose an alternative approach for improved T(1ρ) quantification with the widely-used rotary echo spin-lock pulses in the presence of B(0) inhomogeneities by fitting to a modified theoretical model which is derived to reveal the dependence of T(1ρ)-prepared magnetization on T(1ρ), T(2ρ), spin-lock time, spin-lock frequency and off-resonance, without involving complicated spin-lock pulse design. It has potentials for T(1ρ) quantification improvement at low spin-lock frequencies. Improved T(1ρ) mapping was demonstrated on phantom and in vivo rat spin-lock imaging at 3 T compared to the mapping using the mono-exponential model.

Cardiac 17O MRI: toward direct quantification of myocardial oxygen consumption

A new (17)O-labeled blood contrast agent was injected intravenously in control dogs. Electrocardiogram (ECG)-triggered myocardial T(1)rho imaging was performed to obtain spin-locking T(1)rho-weighted myocardial signals for the detection of resultant metabolite H(2) (17)O water in the heart. Bolus and slow injection methods of various doses of the (17)O-labeled and (16)O-labeled agents were carried out in order to evaluate the sensitivity of this method and determine the optimal injection method. Bolus injection provided approximately 1% signal reduction, whereas slow injection with larger amount of agent yielded 11.9 +/- 0.6% signal reduction. Myocardial oxygen consumption rate was determined by a technique to quantify cerebral oxygenation consumption rate previously developed in (17)O brain studies. With either injection method, myocardial oxygen consumption rate at rest was 5.0 - 5.6 micromol/g/min. Therefore, it appears feasible to detect metabolically generated H(2) (17)O water in vivo in the heart, using the (17)O-labeled blood tracer. Myocardial oxygen consumption rate can then be quantified in vivo, which may open new doors for the assessment of myocardial metabolism.

Change of the cerebrospinal fluid volume during brain activation investigated by T(1rho)-weighted fMRI

A voxel in MRI often contains tissue as well as cerebrospinal fluid (CSF). During functional stimulation, volume fractions of these different water compartments may change. To directly image the CSF volume fraction and measure its functional change, we utilized a rotating-frame longitudinal relaxation time (T(1rho))-weighted MRI technique. At 9.4T with a spin-locking frequency of approximately 500Hz, T(1rho) of tissue water and CSF are about 48 and 450ms, respectively. Therefore, the parenchyma signal becomes negligible when a long spin-locking time (e.g., 200ms) is applied, leaving only the CSF signal. Baseline CSF volume fraction (V(csf)) and its change induced by visual stimulation were mapped in isoflurane-anesthetized cats (n=6). In both T(1rho)-weighted fMRI with spin locking times of 200 and 300ms, negative changes with similar magnitudes were observed, indicating that a decrease in V(csf) is a dominant contributor. In the region with voxels containing the visual cortex and CSF compartments, an average baseline V(csf) was 24.6+/-2%, an average CSF volume fraction change (DeltaV(csf)/V(csf)) was -2.45+/-0.6%, and an absolute change in CSF volume fraction (DeltaV(csf)) was -0.6+/-0.15%. A negative correlation was observed between pixel-wise baseline V(csf) and DeltaV(csf)/V(csf), which can be explained by similar DeltaV(csf) among voxels. Our results suggest that the functional reduction of CSF volume fraction could contribute to fMRI signals, especially when the tissue signal is significantly reduced as compared to the CSF with certain experimental techniques or parameters.

In vivo measurement of plaque burden in a mouse model of Alzheimer's disease

PURPOSE

To demonstrate an MRI method for directly visualizing amyloid-beta (Abeta) plaques in the APP/PS1 transgenic (tg) mouse brain in vivo, and show that T1rho relaxation rate increases progressively with Alzheimer's disease (AD)-related pathology in the tg mouse brain.

MATERIALS AND METHODS

We obtained in vivo MR images of a mouse model of AD (APP/PS1) that overexpresses human amyloid precursor protein, and measured T1rho via quantitative relaxometric maps.

RESULTS

A significant decrease in T1rho was observed in the cortex and hippocampus of 12- and 18-month-old animals compared to their age-matched controls. There was also a correlation between changes in T1rho and the age of the animals.

CONCLUSION

T1rho relaxometry may be a sensitive method for noninvasively determining AD-related pathology in APP/PS1 mice.

Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis

Magnetic resonance imaging (MRI) and quantitative image analysis technology has recently started to generate a great wealth of quantitative information on articular cartilage and bone physiology, pathophysiology and degenerative changes in osteoarthritis. This paper reviews semiquantitative scoring of changes of articular tissues (e.g. WORMS = whole-organ MRI scoring or KOSS = knee osteoarthritis scoring system), quantification of cartilage morphology (e.g. volume and thickness), quantitative measurements of cartilage composition (e.g. T2, T1rho, T1Gd = dGEMRIC index) and quantitative measurement of bone structure (e.g. app. BV/TV, app. TbTh, app. Tb.N, app. Tb.Sp) in osteoarthritis. For each of these fields we describe the hardware and MRI sequences available, the image analysis systems and techniques used to derive semiquantitative and quantitative parameters, the technical accuracy and precision of the measurements reported to date and current results from cross-sectional and longitudinal studies in osteoarthritis. Moreover, the paper summarizes studies that have compared MRI-based measurements with radiography and discusses future perspectives of quantitative MRI in osteoarthritis. In summary, the above methodologies show great promise for elucidating the pathophysiology of various tissues and identifying risk factors of osteoarthritis, for developing structure modifying drugs (DMOADs) and for combating osteoarthritis with new and better therapy.

Rapid 3D-T1ρ mapping of the knee joint at 3.0T with parallel imaging

Three-dimensional spin-lattice relaxation time in the rotating frame (3D-T1rho) with parallel imaging at 3.0T was implemented on a whole-body clinical scanner. A 3D gradient-echo sequence with a self-compensating spin-lock pulse cluster was combined with generalized autocalibrating partially parallel acquisitions (GRAPPA) to acquire T1rho-weighted images. 3D-T1rho maps of an agarose phantom and three healthy subjects were constructed using an eight-channel phased-array coil without parallel imaging and with parallel imaging acceleration factors of 2 and 3, in order to assess the reproducibility of the method. The coefficient of variation (CV) of the median T1rho of the agarose phantom was 0.44%, which shows excellent reproducibility. The reproducibility of in vivo 3D-T1rho maps was also investigated in three healthy subjects. The CV of the median T1rho of the patellar cartilage varied between approximately 1.1% and 4.3%. Similarly, the CV varied between approximately 2.1-5.8%, approximately 1.4-8.7%, and approximately 1.5-4.1% for the biceps femoris and lateral and medial gastrocnemius muscles, respectively. The preliminary results demonstrate that 3D-T1rho maps can be constructed with good reproducibility using parallel imaging. 3D-T1rho with parallel imaging capability is an important clinical tool for reducing both the total acquisition time and RF energy deposition at 3T.

3D-T1ρ quantitation of patellar cartilage at 3.0T

PURPOSE

To demonstrate the feasibility of three-dimensional (3D) T(1rho)-weighted imaging of human knee joint at 3.0T without exceeding the specific absorption rate (SAR) limits and the measurement of the baseline T(1rho) values of patellar cartilage and several muscles at the knee joint.

MATERIALS AND METHODS

3D gradient-echo sequence with a self-compensating spin-lock pulse cluster of 250 Hz power was used to acquire 3D-T(1rho)-weighted images of the knee joint of five healthy subjects. Global and regional analysis of patellar cartilage T(1rho) were performed. Furthermore, T(1rho) of several periarticular muscles were analyzed.

RESULTS

The global average T(1rho) value of the patellar cartilage varied from 39 to 43 msec. The regional average T(1rho) values varied from 38 to 42 msec, and from 42 to 44 msec for medial and lateral facets, respectively. In vivo reproducibility of average T(1rho) of patellar cartilage was found to be 5% (coefficient of variation). Similarly, the global average T(1rho) values for biceps femoris, lateral gastrocnemius, medial gastrocnemius, and sartorius varied between 31-46, 29-49, 35-48, and 32-50 msec, respectively.

CONCLUSION

We demonstrated the feasibility of 3D-T(1rho)-weighted imaging of the knee joint at 3.0T without exceeding SAR limits.

Detection of changes in articular cartilage proteoglycan by T(1rho) magnetic resonance imaging

The purpose of this work is to demonstrate the feasibility of T(1rho)-weighted magnetic resonance imaging (MRI) to quantitatively measure changes in proteoglycan content in cartilage. The T(1rho) MRI technique was implemented in an in vivo porcine animal model with rapidly induced cytokine-mediated cartilage degeneration. Six pigs were given an intra-articular injection of recombinant porcine interleukin-1beta (IL-1beta) into the knee joint before imaging to induce changes in cartilage via matrix metalloproteinase (MMP) induction. The induction of MMPs by IL-1 was used since it has been extensively studied in many systems and is known to create conditions that mimic in part characteristics similar to those of osteoarthritis. The contralateral knee joint was given a saline injection to serve as an internal control. T(1rho)-weighted MRI was performed on a 4 T whole-body clinical scanner employing a 2D fast spin-echo-based T(1rho) imaging sequence. T(1rho) relaxation parameter maps were computed from the T(1rho)-weighted image series. The average T(1rho) relaxation rate, R(1rho) (1/T(1rho)) of the IL-1beta-treated patellae was measured to be on average 25% lower than that of saline-injected patellae indicating a loss of proteoglycan. There was an average reduction of 49% in fixed charge density, measured via sodium MRI, of the IL-1beta-treated patellae relative to control corroborating the loss of proteoglycan. The effects of IL-1beta, primarily loss of PG, were confirmed by histological and immunochemical findings. The results from this study demonstrate that R(1rho) is able to track proteoglycan content in vivo.